Development and preliminary evaluation of a suicidal risk assessment protocol in a randomised controlled trial using the Patient Health Questionnaire (PHQ-9).

Autor: Wileman V; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. vari.wileman@kcl.ac.uk., McGuinness S; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Sweeney L; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Norton C; Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, London, UK., Miller L; Barts and the London Pragmatic Clinical Trials Unit, Queen Mary University of London, London, UK., Stagg I; St Mark's Hospital, The National Bowel Hospital and Academic Institute, London North West Hospitals NHS Trust, London, UK., O'Carroll R; Psychology, Faculty of Natural Sciences, University of Stirling, Stirling, UK., Moss-Morris R; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Jazyk: angličtina
Zdroj: Trials [Trials] 2024 Jul 12; Vol. 25 (1), pp. 476. Date of Electronic Publication: 2024 Jul 12.
DOI: 10.1186/s13063-024-08276-6
Abstrakt: Background: Participants in research trials often disclose severe depression symptoms, including thoughts of self-harm and suicidal ideation, in validated self-administered questionnaires such as the Patient Health Questionnaire (PHQ-9). However, there is no standard protocol for responding to such disclosure, and the opportunity to support people at risk is potentially missed. We developed and evaluated a risk assessment protocol for the IBD-BOOST randomised controlled trial (ISRCTN71618461 09/09/2019).
Methods: Participants completed the PHQ-9 at baseline and 6-month and 12-month follow-ups. The trial database automatically alerted the research team to risk assess participants. Trial researchers, trained in the protocol, contacted participants by telephone, completed the risk assessment, and signposted participants to appropriate professional services.
Results: Seven hundred eighty participants were randomised in the trial; 41 required risk assessment. One participant declined assessment, so 40 risk assessments were completed. Twenty-four participants were assessed as low-risk and 16 participants as medium-risk, with 12 declaring previous suicide attempts. None were rated as high-risk. Trial participants expressed appreciation for being contacted, and all except two wished to receive information about professional support services. Trial risk assessors reported positive experiences of conducting the risk assessment with suggestions for improvement, which resulted in minor modifications to the protocol.
Discussion: Our evaluation demonstrated that it was viable for a research trial team to successfully conduct a risk-assessment protocol for trial participants reporting thoughts of self-harm, with training and support from senior colleagues. Resources are required for training and delivery, but it is not unduly onerous. Trial participants appeared to find completing the assessment acceptable.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje